Stiff competition turns CROs' attention to study startup
Forward-thinking CROs are looking to differentiate themselves and add value to the clinical trial process. Study startup is one place where CROs can get a leg up on the competition.
The CRO market is approaching a tipping point. Market peneration rate is expected to reach 72% by 2020, and the issue of competition looms large.
The process of initiating clinical trials is cumbersome, challenging and often behind schedule. When sponsors look for the right CRO, it will be the CRO with the ability to conduct clinical trials and generate quality data while adhering to timelines and budget.
CROs that embrace ways to operationalize study startup activities using technology can meet, or even best, sponsor's internal metrics for completion of clinical trial tasks. These CROs will stand out as competition stiffens.
Download our white paper "Study Startup: New Battleground in CRO Differentiation Strategy" to learn how purpose-built study startup tools aid CROs in differentiation.
Fill out the form to get your copy today!